Blogs

Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.

Make the Most of Your Data with CancerLinQ Professional Services

By Adam Blair, Manager Oncology Data Quality
As a practice leveraging CancerLinQ products, you’re able to use the SmartLinQ QCP Pathway to seamlessly and automatically track, monitor, and…

Updated August 26, 2021 - Demographics of Patients with Cancer and COVID-19 Disease

CancerLinQ Data
Forty-seven of the CancerLinQ practices providing regular data updates also provided testing information for and/or diagnostic reports of COVID-19…

Unlocking data. Discovering trends. Improving care.

Experience the latest from CancerLinQ Insights: Clinical Data Dashboards

EMPLOYEE SPOTLIGHT: Dr. Danielle Dell Potter

Meet Dr. Danielle Dell Potter, Principal Scientist and Head of Real World Evidence at CancerLinQ.

From One Patient to Millions: Making All the Right Connections

By Jack Aiello
How CancerLinQ uses real-world data to better inform the cancer patient journey

The Future of CancerLinQ - CEO Perspective

By Sean Khozin, MD, MPH
A patient-centered and equitable approach to transforming cancer care and research

Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer

COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019

Impact of COVID-19 Disease on Oncology Practice: Aromatase inhibitors and tamoxifen

CancerLinQ Data
Trends in prescription and/or administration of aromatase inhibitors and tamoxifen by month since January 2019

Impact of COVID-19 Disease on Oncology Practice: Chemotherapy Drug for Breast, Colon and Lung Cancer

COVID-19 Surveillance Report
This is the second in a series of reports on the impacts of COVID-19 disease on the practice of oncology as observed through de-identified CancerLinQ…